Azithromycin for Preventing Bronchopulmonary Dysplasia in Extremely Preterm Infants: A Cohort Study

Documenti analoghi

• Dynamic Risk‐Stratification Models for Bronchopulmonary Dysplasia in Extremely Preterm Very Low Birth Weight Infants
  di: Ting Zhao, et al.
  Pubblicazione: (2025)
• Airway Administration of Budesonide Combined With Pulmonary Surfactant to Prevent Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta‐Analysis
  di: Kaixu Wang, et al.
  Pubblicazione: (2025)
• Respiratory Outcomes Following Late Postnatal Dexamethasone Administration in Preterm Infants With Bronchopulmonary Dysplasia
  di: Melissa House, et al.
  Pubblicazione: (2025)
• Umbilical Artery Leucine‐Rich α‐2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants
  di: Genichiro Sotodate, et al.
  Pubblicazione: (2025)
• Predischarge Betamethasone in Infants Diagnosed With Bronchopulmonary Dysplasia
  di: Tal‐El Ernest, et al.
  Pubblicazione: (2025)